February 18, 2026
TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic approaches to clinical development. Read the full article featuring Janice Chang from Applied Clinical Trials here.
Explore
February 12, 2026
More than a decade ago, a group of pharma R&D heads gathered for an annual meeting focused on addressing common industry challenges. They had a running joke: With an average tenure of just three years, if they wanted to see each other at more than one of these gatherings, they’d better figure out how to…
Explore
February 6, 2026
Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological advances to enable breakthroughs in processes as well as pipelines. Read the full article featuring Rob DiCicco from Citeline here.
Explore
February 3, 2026
When TransCelerate launched more than a decade ago, few expected a collaboration among direct competitors to last, let alone grow into a durable, trusted organization. The numbers were seemingly against us: Most consortia struggle to survive beyond two years, typically dissolving once their founding champions retire or member companies deprioritize their involvement. Read the full…
Explore
